TUMORI J, vol.88, no.6, pp.474-477, 2002 (SCI-Expanded)
Aims and background: Sixty-three patients with local-regionally advanced breast cancer were treated with neoadjuvant chemotherapy consisting of docetaxel (Taxotere), epirubicin, and 5-fluorouracil (TEF).